Keywords
Last Name
Institution

William H. Spencer

Title
InstitutionMedical University of South Carolina
DepartmentCardiology
Address
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Nagueh SF, Groves BM, Schwartz L, Smith KM, Wang A, Bach RG, Nielsen C, Leya F, Buergler JM, Rowe SK, Woo A, Maldonado YM, Spencer WH. Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy. A multicenter North American registry. J Am Coll Cardiol. 2011 Nov 22; 58(22):2322-8. PMID: 22093510.
      View in: PubMed
    2. Quin EM, Cuoco FA, Forcina MS, Coker JB, Yoe RH, Spencer WH, Fernandes VL, Nielsen CD, Sturdivant JL, Leman RB, Wharton JM, Gold MR. Defibrillation thresholds in hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol. 2011 May; 22(5):569-72. PMID: 21091965.
      View in: PubMed
    3. Cuoco FA, Spencer WH, Fernandes VL, Nielsen CD, Nagueh S, Sturdivant JL, Leman RB, Wharton JM, Gold MR. Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy. J Am Coll Cardiol. 2008 Nov 18; 52(21):1718-23. PMID: 19007692.
      View in: PubMed
    4. Fernandes VL, Nielsen C, Nagueh SF, Herrin AE, Slifka C, Franklin J, Spencer WH. Follow-up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy the Baylor and Medical University of South Carolina experience 1996 to 2007. JACC Cardiovasc Interv. 2008 Oct; 1(5):561-70. PMID: 19463359.
      View in: PubMed
    5. Buergler JM, Alam S, Spencer W, Kleiman NS, Melendez Y, Franklin J, Nagueh SF. Initial experience with alcohol septal ablation using a novel magnetic navigation system. J Interv Cardiol. 2007 Dec; 20(6):559-63. PMID: 18042061.
      View in: PubMed
    6. Serber ER, Sears SF, Nielsen CD, Spencer WH, Smith KM. Depression, anxiety, and quality of life in patients with obstructive hypertrophic cardiomyopathy three months after alcohol septal ablation. Am J Cardiol. 2007 Nov 15; 100(10):1592-7. PMID: 17996525.
      View in: PubMed
    7. Nagueh SF, Buergler JM, Quinones MA, Spencer WH, Lawrie GM. Outcome of surgical myectomy after unsuccessful alcohol septal ablation for the treatment of patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 2007 Aug 21; 50(8):795-8. PMID: 17707185.
      View in: PubMed
    8. Simon RD, Crawford FA, Spencer WH, Gold MR. Sustained ventricular tachycardia following alcohol septal ablation for hypertrophic obstructive cardiomyopathy. Pacing Clin Electrophysiol. 2005 Dec; 28(12):1354-6. PMID: 16403169.
      View in: PubMed
    9. Nambi V, Buergler JM, Lakkis NM, Franklin J, Spencer WH, Nagueh SF. Effectiveness of percutaneous intervention for patients with obstructive hypertrophic cardiomyopathy and coronary artery disease. Am J Cardiol. 2005 Aug 15; 96(4):580-1. PMID: 16098315.
      View in: PubMed
    10. Stroud RE, Deschamps AM, Lowry AS, Hardin AE, Mukherjee R, Lindsey ML, Ramamoorthy S, Zile MR, Spencer WH, Spinale FG. Plasma monitoring of the myocardial specific tissue inhibitor of metalloproteinase-4 after alcohol septal ablation in hypertrophic obstructive cardiomyopathy. J Card Fail. 2005 Mar; 11(2):124-30. PMID: 15732032.
      View in: PubMed
    11. Fernandes VL, Nagueh SF, Wang W, Roberts R, Spencer WH. A prospective follow-up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy--the Baylor experience (1996-2002). Clin Cardiol. 2005 Mar; 28(3):124-30. PMID: 15813618.
      View in: PubMed
    12. Chang SM, Lakkis NM, Franklin J, Spencer WH, Nagueh SF. Predictors of outcome after alcohol septal ablation therapy in patients with hypertrophic obstructive cardiomyopathy. Circulation. 2004 Feb 24; 109(7):824-7. PMID: 14967729.
      View in: PubMed
    13. Nagueh SF, Lakkis NM, Middleton KJ, Franklin J, Spencer WH. Images in cardiovascular medicine. Avoiding papillary muscle infarction with myocardial contrast echocardiographic guidance of nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. Circulation. 2004 Feb 10; 109(5):e27-8. PMID: 14769690.
      View in: PubMed
    14. Chang Sm, Sekandarzad MW, Jiang S, Nagueh S, Spencer W, Lakkis N. Impact of infarct size on clinical and echocardiographic outcome in patients undergoing nonsurgical septal reduction therapy. Am Heart J. 2003 Dec; 146(6):1112-4. PMID: 14661008.
      View in: PubMed
    15. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, Spencer WH, Spirito P, Ten Cate FJ, Wigle ED. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol. 2003 Nov 05; 42(9):1687-713. PMID: 14607462.
      View in: PubMed
    16. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, Spencer WH, Spirito P, Ten Cate FJ, Wigle ED. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. Eur Heart J. 2003 Nov; 24(21):1965-91. PMID: 14585256.
      View in: PubMed
    17. Chang SM, Nagueh SF, Spencer WH, Lakkis NM. Complete heart block: determinants and clinical impact in patients with hypertrophic obstructive cardiomyopathy undergoing nonsurgical septal reduction therapy. J Am Coll Cardiol. 2003 Jul 16; 42(2):296-300. PMID: 12875767.
      View in: PubMed
    18. Nielsen CD, Killip D, Spencer WH. Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: short-term results in 50 consecutive procedures. Clin Cardiol. 2003 Jun; 26(6):275-9. PMID: 12839045.
      View in: PubMed
    19. Gold MR, Spencer W. T wave alternans for ventricular arrhythmia risk stratification. Curr Opin Cardiol. 2003 Jan; 18(1):1-5. PMID: 12496495.
      View in: PubMed
    20. Nielsen CD, Fernandes V, Spencer WH. Alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Am Heart Hosp J. 2003; 1(1):83-90. PMID: 15785181.
      View in: PubMed
    21. Bradham WS, Gunasinghe H, Holder JR, Multani M, Killip D, Anderson M, Meyer D, Spencer WH, Torre-Amione G, Spinale FG. Release of matrix metalloproteinases following alcohol septal ablation in hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 2002 Dec 18; 40(12):2165-73. PMID: 12505230.
      View in: PubMed
    22. Keng FY, Chang SM, Cwajg E, He ZX, Lakkis NM, Nagueh SF, Spencer WH, Verani MS. Gated SPECT in patients with hypertrophic obstructive cardiomyopathy undergoing transcoronary ethanol septal ablation. J Nucl Cardiol. 2002 Nov-Dec; 9(6):594-600. PMID: 12466783.
      View in: PubMed
    23. Runquist LH, Nielsen CD, Killip D, Gazes P, Spencer WH. Electrocardiographic findings after alcohol septal ablation therapy for obstructive hypertrophic cardiomyopathy. Am J Cardiol. 2002 Nov 01; 90(9):1020-2. PMID: 12398978.
      View in: PubMed
    24. Buell HE, Stables RH, DeLong ER, Shuping KB, Killip DM, Lever HM, McKenna WJ, Rubin D, Sigwart U, Takayama M, Wagner GS, Eisenstein EL, Spencer WH. Percutaneous transluminal septal reduction for hypertrophic obstructive cardiomyopathy: report from an international pilot study. J Med Syst. 2002 Aug; 26(4):293-300. PMID: 12118813.
      View in: PubMed
    25. Park TH, Lakkis NM, Middleton KJ, Franklin J, Zoghbi WA, Quiñones MA, Spencer WH, Nagueh SF. Acute effect of nonsurgical septal reduction therapy on regional left ventricular asynchrony in patients with hypertrophic obstructive cardiomyopathy. Circulation. 2002 Jul 23; 106(4):412-5. PMID: 12135938.
      View in: PubMed
    26. Nielsen CD, Killip D, Spencer WH. Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy in South Carolina: the MUSC experience (1999 through 2001). J S C Med Assoc. 2002 Apr; 98(2):62-5. PMID: 11975139.
      View in: PubMed
    27. Nielsen CD, Spencer WH. Role of controlled septal infarct in hypertrophic obstructive cardiomyopathy. Cardiol Rev. 2002 Mar-Apr; 10(2):108-18. PMID: 11895577.
      View in: PubMed
    28. Nagueh SF, Ommen SR, Lakkis NM, Killip D, Zoghbi WA, Schaff HV, Danielson GK, Quiñones MA, Tajik AJ, Spencer WH. Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 2001 Nov 15; 38(6):1701-6. PMID: 11704383.
      View in: PubMed
    29. Malanuk RM, Nielsen CD, Spencer WH. Sudden cardiac death in hypertrophic cardiomyopathy. J S C Med Assoc. 2001 Oct; 97(10):424-7. PMID: 11688312.
      View in: PubMed
    30. Lakkis N, Plana JC, Nagueh S, Killip D, Roberts R, Spencer WH. Efficacy of nonsurgical septal reduction therapy in symptomatic patients with obstructive hypertrophic cardiomyopathy and provocable gradients. Am J Cardiol. 2001 Sep 01; 88(5):583-6. PMID: 11524078.
      View in: PubMed
    31. Nagueh SF, Stetson SJ, Lakkis NM, Killip D, Perez-Verdia A, Entman ML, Spencer WH, Torre-Amione G. Decreased expression of tumor necrosis factor-alpha and regression of hypertrophy after nonsurgical septal reduction therapy for patients with hypertrophic obstructive cardiomyopathy. Circulation. 2001 Apr 10; 103(14):1844-50. PMID: 11294801.
      View in: PubMed
    32. Mazur W, Nagueh SF, Lakkis NM, Middleton KJ, Killip D, Roberts R, Spencer WH. Regression of left ventricular hypertrophy after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. Circulation. 2001 Mar 20; 103(11):1492-6. PMID: 11257074.
      View in: PubMed
    33. Flores-Ramirez R, Lakkis NM, Middleton KJ, Killip D, Spencer WH, Nagueh SF. Echocardiographic insights into the mechanisms of relief of left ventricular outflow tract obstruction after nonsurgical septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 2001 Jan; 37(1):208-14. PMID: 11153740.
      View in: PubMed
    34. Sun H, Spencer WH, Khoury DS. Activation effects of single-site and dual-site right atrial pacing in canine. J Interv Card Electrophysiol. 2000 Oct; 4(3):501-9. PMID: 11046189.
      View in: PubMed
    35. Lakkis NM, Nagueh SF, Dunn JK, Killip D, Spencer WH. Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: one-year follow-up. J Am Coll Cardiol. 2000 Sep; 36(3):852-5. PMID: 10987610.
      View in: PubMed
    36. Spencer WH, Roberts R. Alcohol septal ablation in hypertrophic obstructive cardiomyopathy: the need for a registry. Circulation. 2000 Aug 08; 102(6):600-1. PMID: 10931796.
      View in: PubMed
    37. Nagueh SF, Lakkis NM, Middleton KJ, Killip D, Zoghbi WA, Quiñones MA, Spencer WH. Changes in left ventricular filling and left atrial function six months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 1999 Oct; 34(4):1123-8. PMID: 10520801.
      View in: PubMed
    38. Sun H, Velipasaoglu EO, Wu DE, Kopelen HA, Zoghbi WA, Spencer WH, Khoury DS. Simultaneous multisite mapping of the right and the left atrial septum in the canine intact beating heart. Circulation. 1999 Jul 20; 100(3):312-9. PMID: 10411858.
      View in: PubMed
    39. Nagueh SF, Lakkis NM, Middleton KJ, Killip D, Zoghbi WA, Quiñones MA, Spencer WH. Changes in left ventricular diastolic function 6 months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. Circulation. 1999 Jan 26; 99(3):344-7. PMID: 9918519.
      View in: PubMed
    40. Nagueh SF, Lakkis NM, Middleton KJ, Spencer WH, Zoghbi WA, Quiñones MA. Doppler estimation of left ventricular filling pressures in patients with hypertrophic cardiomyopathy. Circulation. 1999 Jan 19; 99(2):254-61. PMID: 9892592.
      View in: PubMed
    41. Lakkis NM, Nagueh SF, Kleiman NS, Killip D, He ZX, Verani MS, Roberts R, Spencer WH. Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy. Circulation. 1998 Oct 27; 98(17):1750-5. PMID: 9788829.
      View in: PubMed
    42. Nagueh SF, Lakkis NM, He ZX, Middleton KJ, Killip D, Zoghbi WA, Quiñones MA, Roberts R, Verani MS, Kleiman NS, Spencer WH. Role of myocardial contrast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 1998 Jul; 32(1):225-9. PMID: 9669274.
      View in: PubMed
    43. Spencer WH, Zhu DW, Kirkpatrick C, Killip D, Durand JB. Subclavian venogram as a guide to lead implantation. Pacing Clin Electrophysiol. 1998 Mar; 21(3):499-502. PMID: 9558679.
      View in: PubMed
    44. Spencer WH, Zhu DW, Markowitz T, Badruddin SM, Zoghbi WA. Atrial septal pacing: a method for pacing both atria simultaneously. Pacing Clin Electrophysiol. 1997 Nov; 20(11):2739-45. PMID: 9392804.
      View in: PubMed
    45. Eagle KA, Brundage BH, Chaitman BR, Ewy GA, Fleisher LA, Hertzer NR, Leppo JA, Ryan T, Schlant RC, Spencer WH, Spittell JA, Twiss RD. Guidelines for perioperative cardiovascular evaluation for noncardiac surgery: an abridged version of the report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Mayo Clin Proc. 1997 Jun; 72(6):524-31. PMID: 9179136.
      View in: PubMed
    46. Lakkis N, Kleiman N, Killip D, Spencer WH. Hypertrophic obstructive cardiomyopathy: alternative therapeutic options. Clin Cardiol. 1997 May; 20(5):417-8. PMID: 9134270.
      View in: PubMed
    47. Zhu DW, Spencer WH. Pacing therapy for atrial tachyarrhythmias. Clin Cardiol. 1996 Sep; 19(9):737-42. PMID: 8874994.
      View in: PubMed
    48. Raghavan C, Cashion WR, Spencer WH. Malposition of transvenous pacing lead in the left ventricle. Clin Cardiol. 1996 Apr; 19(4):335-8. PMID: 8706376.
      View in: PubMed
    49. Eagle KA, Brundage BH, Chaitman BR, Ewy GA, Fleisher LA, Hertzer NR, Leppo JA, Ryan T, Schlant RC, Spencer WH, Spittell JA, Twiss RD, Ritchie JL, Cheitlin MD, Gardner TJ, Garson A, Lewis RP, Gibbons RJ, O'Rourke RA, Ryan TJ. Guidelines for perioperative cardiovascular evaluation for noncardiac surgery. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol. 1996 Mar 15; 27(4):910-48. PMID: 8613622.
      View in: PubMed
    50. Eagle KA, Brundage BH, Chaitman BR, Ewy GA, Fleisher LA, Hertzer NR, Leppo JA, Ryan T, Schlant RC, Spencer WH, Spittell JA, Twiss RD, Ritchie JL, Cheitlin MD, Gardner TJ, Garson A, Lewis RP, Gibbons RJ, O'Rourke RA, Ryan TJ. Guidelines for perioperative cardiovascular evaluation for noncardiac surgery. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Committee on Perioperative Cardiovascular Evaluation for Noncardiac Surgery. Circulation. 1996 Mar 15; 93(6):1278-317. PMID: 8653858.
      View in: PubMed
    51. Crossley GH, Brinker JA, Reynolds D, Spencer W, Johnson WB, Hurd H, Tonder L, Zmijewski M. Steroid elution improves the stimulation threshold in an active-fixation atrial permanent pacing lead. A randomized, controlled study. Model 4068 Investigators. Circulation. 1995 Nov 15; 92(10):2935-9. PMID: 7586262.
      View in: PubMed
    52. Gallik DM, Guidry GW, Mahmarian JJ, Verani MS, Spencer WH. Comparison of ventricular function in atrial rate adaptive versus dual chamber rate adaptive pacing during exercise. Pacing Clin Electrophysiol. 1994 Feb; 17(2):179-85. PMID: 7513403.
      View in: PubMed
    53. Fromm RE, Hoskins E, Cronin L, Pratt CM, Spencer WH, Roberts R. Bleeding complications following initiation of thrombolytic therapy for acute myocardial infarction: a comparison of helicopter-transported and nontransported patients. Ann Emerg Med. 1991 Aug; 20(8):892-5. PMID: 1906690.
      View in: PubMed
    54. Spencer WH, Markowitz T, Alagona P. Rate augmentation and atrial arrhythmias in DDDR pacing. Pacing Clin Electrophysiol. 1990 Dec; 13(12 Pt 2):1847-51. PMID: 1704552.
      View in: PubMed
    55. Rodgers G, Ruplinger J, Spencer W, Cronin L, Kleiman N, Nelson J, Roberts R, Pratt C. Helicopter transport of patients with acute myocardial infarction. Tex Med. 1988 Oct; 84(10):35-7. PMID: 3232109.
      View in: PubMed
    56. Nielsen AP, Cashion WR, Spencer WH, Norton HJ, Divine GW, Schuenemeyer TD, Griffin JC. Long-term assessment of unipolar and bipolar stimulation and sensing thresholds using a lead configuration programmable pacemaker. J Am Coll Cardiol. 1985 May; 5(5):1198-204. PMID: 3989132.
      View in: PubMed
    57. Lawrie GM, Morris GC, Howell JF, Ogura JW, Spencer WH, Cashion WR, Winters WL, Beazley HL, Chapman DW, Peterson PK, Lie JT. Results of coronary bypass more than 5 years after operation in 434 patients. Clinical, treadmill exercise and angiographic correlations. Am J Cardiol. 1977 Nov; 40(5):665-72. PMID: 303457.
      View in: PubMed
    58. Spencer WH, Behar VS, Orgain ES. Apex cardiogram in patients with prolapsing mitral valve. Am J Cardiol. 1973 Sep 07; 32(3):276-82. PMID: 4725581.
      View in: PubMed
    Spencer's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description